A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013)

The purpose of this study is to learn what happens to MK-6916 in a person's body when given to participants with moderate or severe kidney impairment compared to healthy participants.

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: Moderate and Severe Renal Impairment * Except for severe or moderate renal impairment, is sufficiently healthy for study participation * Has stable renal function Healthy * Matches mean age to participants with moderate and severe renal impairment Exclusion Criteria: The main exclusion criteria include but are not limited to the following: All participants * Has history of cancer (malignancy) * Has positive test(s) for hepatitis B surface antigen (HBsAg), hepatitis C antibodies, or human immunodeficiency virus (HIV) * Has had major surgery and/or donated or lost 1 unit of blood within 4 weeks prior to pretrial Participants with Renal Impairment * Has a history of renal artery stenosis, failed renal transplant or has had a nephrectomy, or end stage renal disease requiring dialysis